Ken Keller

President and Chief Executive Officer Daiichi Sankyo, Inc.

Ken joined Daiichi Sankyo in 2014 serving as president of the commercial and administration division. Ken is also the president and ceo of American Regent Inc. a Daiichi Sankyo company.  Prior to joining Daiichi-Sankyo Inc., Ken was president and chief operating officer of Spectrum Pharmaceutical Inc. Ken gained significant experience in his 21 years at Amgen Inc. He served as vice president and general manager of multiple business units from 2006 to 2012. And he was managing director of the United Kingdom and Ireland affiliate from 2003-2006  During his career at Amgen, Ken held positions as marketing lead or the general manager for four of the world’s top selling biologic medicines. Ken started his career at Beecham Laboratories as a professional sales representative in 1985.

Ken earned a Bachelor’s of Science degree in Business from Saint John’s University in 1984 and a Masters in Business Administration from Loyola Marymount University in 2001.